| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.076 | 0.1 |